MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis
USA - NASDAQ:MDLZ - US6092071058 - Common Stock
63.71 USD
+0.46 (+0.73%)
63.71 USD
0 (0%)
Overall MDLZ gets a fundamental rating of 5 out of 10. We evaluated MDLZ against 89 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are some minor concerns on its financial health. MDLZ has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
MDLZ had positive earnings in each of the past 5 years.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
MDLZ has a better Return On Assets (5.13%) than 71.91% of its industry peers.
Looking at the Return On Equity, with a value of 13.90%, MDLZ belongs to the top of the industry, outperforming 80.90% of the companies in the same industry.
The Return On Invested Capital of MDLZ (6.99%) is better than 69.66% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.31%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROIC | 6.99% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ has a Profit Margin of 9.81%. This is amongst the best in the industry. MDLZ outperforms 84.27% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has declined.
MDLZ has a better Operating Margin (13.22%) than 79.78% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a better Gross Margin (32.55%) than 75.28% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
MDLZ has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
MDLZ has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.44 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score of 2.44. This is comparable to the rest of the industry: MDLZ outperforms 58.43% of its industry peers.
The Debt to FCF ratio of MDLZ is 7.30, which is on the high side as it means it would take MDLZ, 7.30 years of fcf income to pay off all of its debts.
MDLZ has a better Debt to FCF ratio (7.30) than 67.42% of its industry peers.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio (0.76) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Altman-Z | 2.44 |
ROIC/WACC0.92
WACC7.58%
2.3 Liquidity
A Current Ratio of 0.64 indicates that MDLZ may have some problems paying its short term obligations.
The Current ratio of MDLZ (0.64) is worse than 88.76% of its industry peers.
MDLZ has a Quick Ratio of 0.64. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a worse Quick ratio (0.39) than 82.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 |
3. Growth
3.1 Past
MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.37%.
MDLZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.91% yearly.
The Revenue has been growing slightly by 3.14% in the past year.
MDLZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.09% yearly.
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.92% yearly.
The Revenue is expected to grow by 4.19% on average over the next years.
EPS Next Y-10.57%
EPS Next 2Y-0.8%
EPS Next 3Y2.75%
EPS Next 5Y4.92%
Revenue Next Year5.47%
Revenue Next 2Y5.02%
Revenue Next 3Y4.63%
Revenue Next 5Y4.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.49, which indicates a rather expensive current valuation of MDLZ.
The rest of the industry has a similar Price/Earnings ratio as MDLZ.
MDLZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
MDLZ is valuated rather expensively with a Price/Forward Earnings ratio of 18.76.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 67.42% of the companies are valued more expensively.
MDLZ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 18.76 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA ratio is in line with the industry average.
MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 65.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.81 | ||
| EV/EBITDA | 15.97 |
4.3 Compensation for Growth
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.96
EPS Next 2Y-0.8%
EPS Next 3Y2.75%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.22%. Purely for dividend investing, there may be better candidates out there.
MDLZ's Dividend Yield is a higher than the industry average which is at 5.03.
MDLZ's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
66.77% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP66.77%
EPS Next 2Y-0.8%
EPS Next 3Y2.75%
63.71
+0.46 (+0.73%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners86.73%
Inst Owner Change-1.37%
Ins Owners0.14%
Ins Owner Change0.34%
Market Cap82.44B
Analysts76.57
Price Target75.03 (17.77%)
Short Float %1.96%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP66.77%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.87%
Min EPS beat(2)5.55%
Max EPS beat(2)10.18%
EPS beat(4)3
Avg EPS beat(4)6.73%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)5.91%
EPS beat(12)11
Avg EPS beat(12)6.02%
EPS beat(16)13
Avg EPS beat(16)5.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.25%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.41%
Revenue beat(12)5
Avg Revenue beat(12)0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.51%
PT rev (1m)-0.08%
PT rev (3m)2.26%
EPS NQ rev (1m)-2.47%
EPS NQ rev (3m)-9.59%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)3.07%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 18.76 | ||
| P/S | 2.22 | ||
| P/FCF | 28.81 | ||
| P/OCF | 19.8 | ||
| P/B | 3.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.97 |
EPS(TTM)3.11
EY4.88%
EPS(NY)3.4
Fwd EY5.33%
FCF(TTM)2.21
FCFY3.47%
OCF(TTM)3.22
OCFY5.05%
SpS28.68
BVpS20.24
TBVpS-13.82
PEG (NY)N/A
PEG (5Y)2.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROCE | 9.6% | ||
| ROIC | 6.99% | ||
| ROICexc | 7.19% | ||
| ROICexgc | 51.08% | ||
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% | ||
| FCFM | 7.71% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Debt/EBITDA | 3.17 | ||
| Cap/Depr | 98.04% | ||
| Cap/Sales | 3.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 66.77% | ||
| Profit Quality | 78.58% | ||
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.44 |
F-Score5
WACC7.58%
ROIC/WACC0.92
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
EPS Next Y-10.57%
EPS Next 2Y-0.8%
EPS Next 3Y2.75%
EPS Next 5Y4.92%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
Revenue Next Year5.47%
Revenue Next 2Y5.02%
Revenue Next 3Y4.63%
Revenue Next 5Y4.19%
EBIT growth 1Y-22.49%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year10.54%
EBIT Next 3Y8.45%
EBIT Next 5Y8.23%
FCF growth 1Y-1.28%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y6.39%
OCF growth 3Y5.84%
OCF growth 5Y4.37%